Literature DB >> 12094882

Botulinum toxin for the treatment of gastroparesis: a preliminary report.

Brian E Lacy1, Estephan N Zayat, Michael D Crowell, Marvin M Schuster.   

Abstract

Gastroparesis is a disorder of gastric motility that results in delayed gastric emptying. Common symptoms include early satiety, postprandial fullness, epigastric pain, nausea, vomiting, and weight loss. The underlying etiologies of gastroparesis are many and include diabetes, prior gastric surgery, collagen vascular disorders, and a previous viral illness. Up to one third of cases are classified as idiopathic. Treatment typically consists of a change in diet to small volume, frequent meals and the use of the prokinetic agents metoclopramide, cisapride, erythromycin, or domperidone. Botulinum toxin has recently been shown to be effective in treating disorders of smooth muscle hypertonicity in the GI tract. This case report describes three patients with severe gastroparesis whose symptoms persisted despite dietary changes and the use of high dose prokinetic agents. All three were treated with intrasphincteric injection of the pylorus with botulinum toxin and all had significant symptomatic improvement afterwards. Possible mechanisms of action of botulinum toxin on the pylorus and its effects in patients with gastroparesis are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12094882     DOI: 10.1111/j.1572-0241.2002.05741.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  26 in total

Review 1.  The use of botulinum toxin for the treatment of gastrointestinal motility disorders.

Authors:  Frank Friedenberg; Satya Gollamudi; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

2.  Treatment of Gastroparesis.

Authors:  Daniel C. Buckles; Richard W. McCallum
Journal:  Curr Treat Options Gastroenterol       Date:  2004-04

Review 3.  Botulinum Toxin Injection for Treatment of Gastroparesis.

Authors:  Trisha S Pasricha; Pankaj J Pasricha
Journal:  Gastrointest Endosc Clin N Am       Date:  2018-09-28

Review 4.  An update on autonomic neuropathy affecting the gastrointestinal tract.

Authors:  Liza K Phillips; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

5.  Factors associated with symptom response to pyloric injection of botulinum toxin in a large series of gastroparesis patients.

Authors:  Radoslav Coleski; Michelle A Anderson; William L Hasler
Journal:  Dig Dis Sci       Date:  2009-12       Impact factor: 3.199

Review 6.  Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting.

Authors:  H P Parkman; M Camilleri; G Farrugia; R W McCallum; A E Bharucha; E A Mayer; J F Tack; R Spiller; M Horowitz; A I Vinik; J J Galligan; P J Pasricha; B Kuo; L A Szarka; L Marciani; K Jones; C R Parrish; P Sandroni; T Abell; T Ordog; W Hasler; K L Koch; K Sanders; N J Norton; F Hamilton
Journal:  Neurogastroenterol Motil       Date:  2009-12-09       Impact factor: 3.598

Review 7.  Gastroparesis: pathogenesis, diagnosis and management.

Authors:  William L Hasler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-19       Impact factor: 46.802

8.  Effectiveness and feasibility of robotic gastric neurostimulator placement in patients with refractory gastroparesis.

Authors:  Mia Mowzoon; Francisco Igor B Macedo; Jaskiran Kaur; Ramachandra Kolachalam
Journal:  J Robot Surg       Date:  2017-07-20

9.  Current and Emerging Therapeutic Options for Gastroparesis.

Authors:  Aung S Myint; Brandon Rieders; Mohammed Tashkandi; Marie L Borum; Joyce M Koh; Sindu Stephen; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-11

10.  Idiopathic and Diabetic Gastroparesis.

Authors:  Deirdre O'Donovan; Christine Feinle-Bisset; Karen Jones; Michael Horowitz
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.